Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satish Keshav

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
BMC Infectious Diseases|August 21, 2007
The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosisSanjay Lala, Keertan Dheda, Jung-Su Chang, et al.
Journal of Crohn'S & Colitis|November 17, 2018
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective AnalysisAlissa Walsh, Andrey Kormilitzin, Christopher Hinds, et al.
Journal of Crohn'S & Colitis|November 19, 2016
Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative ColitisMarianne Guirgis, Emily Wendt, Lai Mun Wang, et al.
Ophthalmology and Therapy|June 3, 2026
Safety of GBL1204-An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I StudyAmit Saraf, Kushal Garima, Sandhya Dharwadkar, et al.
Journal of Clinical Microbiology|September 24, 2011
Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infectionNicole Stoesser, Derrick W Crook, Rowena Fung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Gut|October 12, 2014
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa studySilvio Danese, Janusz Rudziński, Wolfgang Brandt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2025
Navigating the Hepatic Immune Landscape With Fine Needle Aspiration of the Liver-An Emerging TechniqueKate Diana Lynch, Fabiola Curion, Hing-Yuen Yeung, et al.
Journal of Crohn'S & Colitis|May 17, 2018
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe DiseaseWilliam J Sandborn, Bal R Bhandari, Charles Randall, et al.
Journal of Crohn'S & Colitis|December 22, 2010
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit toolAndrea Cassinotti, Satish Keshav, Sandro Ardizzone, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
BMC Infectious Diseases|August 21, 2007
The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosisSanjay Lala, Keertan Dheda, Jung-Su Chang, et al.
Journal of Crohn'S & Colitis|November 17, 2018
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective AnalysisAlissa Walsh, Andrey Kormilitzin, Christopher Hinds, et al.
Journal of Crohn'S & Colitis|November 19, 2016
Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative ColitisMarianne Guirgis, Emily Wendt, Lai Mun Wang, et al.
Ophthalmology and Therapy|June 3, 2026
Safety of GBL1204-An Ophthalmic Bevacizumab in Prefilled Syringe for Neovascular Age-Related Macular Degeneration: A Phase I StudyAmit Saraf, Kushal Garima, Sandhya Dharwadkar, et al.
Journal of Clinical Microbiology|September 24, 2011
Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infectionNicole Stoesser, Derrick W Crook, Rowena Fung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 26, 2020
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitisEmma L Culver, Helen K Bungay, Margaret Betts, et al.
Gut|October 12, 2014
Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa studySilvio Danese, Janusz Rudziński, Wolfgang Brandt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2025
Navigating the Hepatic Immune Landscape With Fine Needle Aspiration of the Liver-An Emerging TechniqueKate Diana Lynch, Fabiola Curion, Hing-Yuen Yeung, et al.
Journal of Crohn'S & Colitis|May 17, 2018
Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe DiseaseWilliam J Sandborn, Bal R Bhandari, Charles Randall, et al.
Journal of Crohn'S & Colitis|December 22, 2010
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit toolAndrea Cassinotti, Satish Keshav, Sandro Ardizzone, et al.
Pageof 4